Showing results (641-650 of 1,609) with videos related to

Sort By:
Pageof 161
JAMA Oncology|May 24, 2019
Association of Black Race With Prostate Cancer-Specific and Other-Cause MortalityRobert T Dess, Holly E Hartman, Brandon A Mahal, et al.
JAMA Oncology|June 7, 2019
Evaluation of Readministration of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With CancerAudrey Simonaggio, Jean Marie Michot, Anne Laure Voisin, et al.
JAMA Oncology|June 21, 2019
Association Between Anesthesia Exposure and Neurocognitive and Neuroimaging Outcomes in Long-term Survivors of Childhood Acute Lymphoblastic LeukemiaPia Banerjee, Michael G Rossi, Doralina L Anghelescu, et al.
JAMA Oncology|April 12, 2019
Current Landscape of Immunotherapy in Breast Cancer: A ReviewSylvia Adams, Margaret E Gatti-Mays, Kevin Kalinsky, et al.
JAMA Oncology|October 28, 2021
Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set: An International Agency for Research on Cancer TP53 Database AnalysisChristian P Kratz, Claire Freycon, Kara N Maxwell, et al.
JAMA Oncology|October 7, 2021
Fulvestrant-Palbociclib vs Letrozole-Palbociclib as Initial Therapy for Endocrine-Sensitive, Hormone Receptor-Positive, ERBB2-Negative Advanced Breast Cancer: A Randomized Clinical TrialAntonio Llombart-Cussac, José Manuel Pérez-García, Meritxell Bellet, et al.
JAMA Oncology|October 7, 2021
Nodal Recurrence in Patients With Node-Positive Breast Cancer Treated With Sentinel Node Biopsy Alone After Neoadjuvant Chemotherapy-A Rare EventAndrea V Barrio, Giacomo Montagna, Anita Mamtani, et al.
JAMA Oncology|October 18, 2019
Haploidentical Stem Cell Transplantation With Posttransplant Cyclophosphamide Therapy vs Other Donor Transplantations in Adults With Hematologic Cancers: A Systematic Review and Meta-analysisNico Gagelmann, Andrea Bacigalupo, Alessandro Rambaldi, et al.
JAMA Oncology|October 25, 2021
Effect of Elective Internal Mammary Node Irradiation on Disease-Free Survival in Women With Node-Positive Breast Cancer: A Randomized Phase 3 Clinical TrialYong Bae Kim, Hwa Kyung Byun, Dae Yong Kim, et al.
JAMA Oncology|March 3, 2022
Efficacy of HD201 vs Referent Trastuzumab in Patients With ERBB2-Positive Breast Cancer Treated in the Neoadjuvant Setting: A Multicenter Phase 3 Randomized Clinical TrialXavier Pivot, M A Georgievich, Volodymyr Shamrai, et al.
Pageof 161